EPALEX
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a seizure warning sign (aura) occurs, the patient will be able to prevent the development of a full-blown seizure through the use of a pocket nebulizer to deliver a powerful antiseizure medication that rapidly enters the brain and stops the seizure. The effect of the drug dissipates within minutes, allowing the patient to resume normal daily activity. The inhaler is also used to stop migraine attacks that are refractory to currently available migraine treatments.
EPALEX
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2009-01-01
Address:
Palo Alto, California, United States
Country:
United States
Website Url:
http://www.epalex.com
Total Employee:
1+
Status:
Active
Contact:
(650) 346-3380
Total Funding:
11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Apache Microsoft Exchange Online Office 365 Mail Google Maps
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Neurana Pharmaceuticals
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Current Employees Featured
Steven Krill Chief Development Officer @ Epalex
Chief Development Officer
Michael Rogawski Co-Founder @ Epalex
Co-Founder
Brendan Magrab CEO @ Epalex
CEO
2019-01-01
Randall Murphy Co-Founder & Board Member @ Epalex
Co-Founder & Board Member
Founder
Official Site Inspections
http://www.epalex.com Semrush global rank: 6.17 M Semrush visits lastest month: 1.31 K
- Host name: vps67589.inmotionhosting.com
- IP address: 199.223.115.138
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Epalex"
Epalex Breakthrough Therapies for Migraine and Epilepsy
EP103 is a mechanistically novel, broad-spectrum antiseizure agent under development by Epalex for people suffering with drug-refractory epilepsy. EP103 may be particularly useful in treating seizure emergencies because the …See details»
Epalex - Crunchbase Company Profile & Funding
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain …See details»
Epalex 2025 Company Profile: Valuation, Funding
Epalex was founded in 2009. Where is Epalex headquartered? Epalex is headquartered in Mountain View, CA. What is the size of Epalex? Epalex has …See details»
Epalex Corporation - LinkedIn
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a ...See details»
Epalex Corporation Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Epalex Corporation of Mountain View, CA. Get the latest business insights from Dun & Bradstreet.See details»
Epalex - VentureRadar
EpaleX is devoted to the development of novel breakthrough treatments to improve the quality of life for people with epilepsy or migraine. The products are designed for self-administration by …See details»
Epalex Corporation Overview | SignalHire Company Profile
Epalex Corporation is a private company that has been in the industry for 15 years. The company currently specializes in the Pharmaceuticals area. ... Organization Website: epalex.com : …See details»
Epalex Corporation in South San Francisco CA - Company Profile
Sep 16, 2013 Epalex Corporation Overview. Epalex Corporation filed as a Statement & Designation By Foreign Corporation in the State of California on Monday, September 16, 2013 …See details»
Epalex Company Profile - Office Locations, Competitors, Revenue …
Epalex is a company devoted to the development of treatments to improve the quality of life for people with migraines and epilepsy. It offers EP-102 and EP-103, treatments for acute …See details»
Epalex - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Epalex - Contacts, Employees, Board Members, Advisors & Alumni
Epalex is developing a novel inhaled treatment for epilepsy and migraine.See details»
Epalex - Org Chart, Teams, Culture & Jobs - The Org
View Epalex's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Epalex - Overview, News & Similar companies | ZoomInfo.com
Who is Epalex. The research programs of EpaleX have been supported by the University of California, Davis; the Epilepsy Therapy Project; the Epilepsy Foundation o f America; and the …See details»
Our Focus – Epalex Breakthrough Therapies for Migraine and …
The Epalex drug development candidates have a unique mechanism of action that is differentiated from existing therapies. Site Links. Home; Our Medicine; Our Focus; Our People; …See details»
Epalex Corporation - Company Profile & Staff Directory - ContactOut
EpaleX is developing a novel inhaled treatment for epilepsy and migraine. The treatment for the first time provides a way for patients with epilepsy to gain control over their seizures. When a …See details»
Epalex - Products, Competitors, Financials, Employees, …
Epalex is a clinical-stage pharmaceutical company that focuses on developing therapies for migraine and epilepsy. The company offers treatments that feature a unique mechanism of …See details»
Epalex Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Epalex Corp. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Small molecule drug ...See details»
Our Medicine – Epalex Breakthrough Therapies for Migraine and …
EP103 For Epilepsy . Epalex is developing EP103 for the control of seizure disorders resistant to available therapies. EP103 is an oral formulation that can deliver therapeutic levels of an FDA …See details»
Epalex - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Epalex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 3. About. Epalex is actively …See details»
Epalex Corp. (Epalex Corp.) - 药物管线_专利_临床试验_投融营收_最 …
了解Epalex Corp. (Epalex Corp.)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:神经系统疾病，技术平台:小分子化药，药物:EP-102 (Epalex)，EP-103 (Epalex)。See details»